NTELAQ Trademark

Trademark Overview


On Tuesday, November 17, 2015, a trademark application was filed for NTELAQ with the United States Patent and Trademark Office. The USPTO has given the NTELAQ trademark a serial number of 79180965. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, November 21, 2021. This trademark is owned by Novartis AG. The NTELAQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infect...
ntelaq

General Information


Serial Number79180965
Word MarkNTELAQ
Filing DateTuesday, November 17, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, November 21, 2021
Registration Number4971230
Registration DateTuesday, June 7, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, June 21, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Tuesday, June 21, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, May 29, 2020NOTIFICATION PROCESSED BY IB
Friday, September 27, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, September 27, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, December 16, 2016NOTIFICATION PROCESSED BY IB
Thursday, July 7, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 7, 2016FINAL DISPOSITION PROCESSED
Thursday, July 7, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 7, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2016NOTICE OF PUBLICATION
Friday, February 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 5, 2016ASSIGNED TO EXAMINER
Tuesday, February 2, 2016APPLICATION FILING RECEIPT MAILED
Thursday, January 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 22, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 21, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB